✦ LIBER ✦

Induction of DT-diaphorase by doxorubicin and combination therapy with mitomycin C in vitro

✍ Scribed by Asher Begleiter; Marsha K. Leith

Book ID: 115784394
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 653 KB
Volume: 50
Category: Article
ISSN: 0006-2952
DOI: 10.1016/0006-2952(95)02014-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Involvement of NF-κB in the induction of

Involvement of NF-κB in the induction of NAD(P)H: Quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C

✍ Kang-Shen Yao; Peter J. O'Dwyer 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 816 KB

In vitro toxicity to breast cancer cells

In vitro toxicity to breast cancer cells of microsphere-delivered mitomycin C and its combination with doxorubicin

✍ Richard Y. Cheung; Andrew M. Rauth; Patrick T. Ronaldson; Reina Bendayan; Xiao Y 📂 Article 📅 2006 🏛 Elsevier Science 🌐 French ⚖ 307 KB

Relevance of DT-diaphorase activity to m

Relevance of DT-diaphorase activity to mitomycin C (MMC) efficacy on human cancer cells: Differences in in vitro and in vivo systems

✍ Masahiko Nishiyama; Shuji Saeki; Kenjiro Aogi; Naoki Hirabayashi; Tetsuya Toge 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 510 KB

Using 4 human cancer cell lines, 4 tumors xenografted into nude mice, and I I fresh tumor specimens removed at surgery, we investigated the relevance of NAD(P)H:quinone oxidoreductase (DT-diaphorase, DTD) activity (nmoles/min/mg protein) to mitomycin C (MMC)-induced cytotoxicity. In culture cell lin

Combination therapy with radiation and m

Combination therapy with radiation and mitomycin C: Preliminary results with EMT6 tumor cells in vitro and in vivo

✍ Sara Rockwell; Katherine A Kennedy 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 423 KB

Combination therapy with misonidazole an

Combination therapy with misonidazole and mitomycin C: Lack of chemosensitization of EMT6 tumor cells in vivo or in vitro

✍ Sara Rockwell 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 463 KB

A combination therapy with mitomycin c,

A combination therapy with mitomycin c, etoposide, doxifluridine and medroxyprogesterone acetate as second line therapy for advanced breast cancer refractory to combination chemotherapy of cyclophosphamide, doxorubicin and 5 fluorouracil

✍ Katsumasa Kuroi; Akihiko Osaki; Hiroyuki Kawami; Shigeru Murakami; Tetsuya Toge 📂 Article 📅 1997 🏛 Springer Japan 🌐 English ⚖ 374 KB